Publication Topic

Hooda N, Svane HML, Fryzek J, Nicoholson G, White JB, Edris B, Smith LM, Petersen MM, et al. The epidemiology of desmoid tumors in Denmark. Poster presented at the Connective Tissue Oncology Society Annual Meeting, November 2021.

Erber L, Goodman S, Jokipii Krueger CC, Rusyn I, Tretyakova N. 2021. Quantitative nanoLC/NSI⁺-HRMS method for 1,3-butadiene induced bis-N7-guanine DNA-DNA cross-links in urine. Toxics 9(10):247; doi: 10.3390/toxics9100247. PMID: 34678943.

Frankenfeld CL, Leslie TF, Menon NM. 2021. Longer time-to-treatment but better survival for colorectal cancer patients presumptively not diagnosed in a hospital. Cancer Causes Control 32(10):1185–1191; doi: 10.1007/s10552-021-01464-8. PMID: 34160709.

Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer 125(10):1432-1442; doi: 10.1038/s41416-021-01498-4. PMID: 34426664.

Nielson CM, Bylsma LC, Fryzek JP, Saad HA, Crawford J. 2021. Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: A systematic review and meta-analysis. Oncologist 26(9):e1609–e1618; doi: 10.1002/onco.13822. PMID: 33973301.

Hathway J, Miller-Wilson L, Sharma A, Jensen I, Yao W, Raza S, et al. 2021. The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population. J Mark Access Health Policy, 9(1):1948670; doi: 10.1080/20016689.2021.1948670. PMID: 34512929.

Gillezeau C, Movva N, Fryzek J, Rabon-Stith K, Brohawn PZ, Gerwen M van, Taioli E. Molecular epidemiology study of interferon gamma (IFN-γ) expression in urothelial bladder cancer (UBC). Poster presentation, 37^th ICPE (International Conference on Pharmacoepidemiology & Therapeutic Rick Management), virtual conference, August 2021.

Bylsma L, Nielson C, Fryzek J, Saad H, Crawford J. Edit chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. Poster presentation,  37^th ICPE (International Conference on Pharmacoepidemiology & Therapeutic Rick Management), Virtual, August 2021.

Revollo JR, McKinzie PB, Robison TW, Dobrovolsky VN. 2021. Mutational signatures in T-lymphocytes of rats treated with N-propyl-N-nitrosourea and procarbazine. Environ Mol Mutagen 62(6):350-363; doi: 10.1002/em.22448. PMID: 34117657.

Yin W, Nie Z, Dingley K, Trzoss M, Krilov G, Marshall N et al. 2021. Characterization of potent paracaspase MALT1 inhibitors for hematological malignancies. Blood 138 (Sup 1):1187; doi: 10.1182/blood-2021-153159.

Alexander DD, Pastula ST, Riordan AS. 2021. Epidemiology of lung cancer among acrylonitrile-exposed study populations: A meta-analysis. Regul Toxicol Pharmacol 122(June):104896; doi: 10.1016/j.yrtph.2021.104896. PMID: 33617939.

Proctor DM, Bhat V, Suh M, Reichert H, Jiang X, Thompson CM. 2021. Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches. Regul Toxicol Pharmacol 124(August):104969; doi: 10.1016/j.yrtph.2021.104969. PMID: 34089813.

Ierardi AM, Lotter JT, Jacobs N, Finley BL, Pierce JS. Derivation of a proposed asbestiform tremolite NOAEL for lung cancer. Virtual poster Presentation at Society of Toxicology 60^th Annual Meeting, Virtual, 2021.

Chappell GA, Wikoff DS, Thompson CM. 2021. Assessment of mechanistic data for hexavalent chromium-induced rodent intestinal cancer using the key characteristics of carcinogens. Toxicol Sci 180(1):38–50; doi: 10.1093/toxsci/kfaa187. PMID: 33404626.

Hathway J, Miller-Wilson L, Yao W, Jensen I, Weinstein M, Parks P. 2021. The health economic impact of varying levels of adherence to colorectal screening on providers and payers. J Med Econ 24(1):69–78; doi: 10.1080/13696998.2020.1858607. PMID: 33970747.

Li S, Liu J, Gong T, Guo H, Gawade PL, Kelsh MA, et al. 2020. Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer. J Geriatr Oncol 11(8):1309–1315; doi: 10.1016/j.jgo.2020.06.018. PMID: 32624415.

Ravandi F, Pierce S, Garcia-Manero G, Kadia T, Jabbour E, Borthakur G, … Kelsh M, et al. 2020. Salvage therapy outcomes in a historical cohort of patients with relapsed or refractory acute myeloid leukemia. Clin Lymphoma Myeloma Leuk 20(11):e871–e882; doi: 10.1016/j.clml.2020.06.007. PMID: 32792304.

Gentry R, Thompson CM, Franzen A, Salley J, Albertini R, Lu K, Greene T. 2020. Using mechanistic information to support evidence integration and synthesis: A case study with inhaled formaldehyde and leukemia. Crit Rev Toxicol 50(10):885–918; doi: 10.1080/10408444.2020.1854678. PMID: 33538218.

Saldanha G, Ording AG, Bylsma LC, Darvalics B, Solis D, Tang JY, Sorensen HT, Fryzek J. 2020. High frequency basal cell carcinoma (BCC) in Danish patients: Prevalence and consistency. J Eur Acad Dermatol Venereol 34(10):e646-e648; doi: 10.1111/jdv.16512. PMID: 32314479.

Levin-Sparenberg E, Bylsma LC, Lowe K, Sangare L, Fryzek JP, Alexander DD. 2020. A systematic literature review and meta-analysis describing the prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer. Gastroenterol Res 13(5):184–198; doi: 10.14740/gr1167. PMID: 33224365.